Effect of respiratory pathology on the quality of life for patients, suffering from rheumatoid arthritis

T. Pertseva, L. Botvinikova, Y. Guba (Dnepropetrovsk, Ukraine)

Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Session: Respiratory manifestations of systemic disease: a holistic approach
Session type: Thematic Poster Session
Number: 597
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Pertseva, L. Botvinikova, Y. Guba (Dnepropetrovsk, Ukraine). Effect of respiratory pathology on the quality of life for patients, suffering from rheumatoid arthritis. Eur Respir J 2012; 40: Suppl. 56, 597

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Physical activity and quality of life in subjects with chronic diseases; COPD compared to rheumatoid arthritis and diabetes
Source: Annual Congress 2008 - Rehabilitation and influencing factors
Year: 2008



Risk of obstructive sleep apnea in patients with rheumatoid arthritis and its impact on quality of life
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019

Predicting outcomes in rheumatoid arthritis related interstitial lung disease
Source: Eur Respir J, 53 (1) 1800869; 10.1183/13993003.00869-2018
Year: 2019



Influence of symptoms on quality of life in sarcoidosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 32s
Year: 2005

Effects of infliximab on systemic features in patients with COPD suffering from cachexia
Source: Eur Respir J 2006; 28: Suppl. 50, 105s
Year: 2006

Duration of rheumatoid arthritis and the risk of developing interstitial lung disease
Source: ERJ Open Res, 7 (1) 00633-2020; 10.1183/23120541.00633-2020
Year: 2021



Mortality and clinical features in rheumatoid arthritis and interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

The frequency of the respiratory comorbidities in patients (pts) with rheumatoid arthritis (RA)
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021


Risk factors of interstitial lung diseases in patients with rheumatoid arthritis.
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Rituximab improves interstitial lung disease in rheumatoid arthritis patients
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

Analysis of lung diseases associated with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 307s
Year: 2006

Pulmonary manifestations in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 100s
Year: 2006

Impact on patients' health status following early identification of a COPD exacerbation
Source: Eur Respir J 2007; 30: 907-913
Year: 2007



Prognosis symptoms, quality of life and comorbidity relationship with cough in patients with idiopathic pulmonary fibrosis
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019

Effects of infliximab on local and systemic inflammation in patients with COPD suffering from cachexia
Source: Eur Respir J 2006; 28: Suppl. 50, 105s
Year: 2006

Interstitial lung disease in patients with rheumatoid arthritis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

Nutritional status and health-related quality of life (HRQL) in patients admitted to hospital with acute exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 235s
Year: 2002

Are smoking and COPD associated with ILD onset in rheumatoid arthritis?
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


The lung in rheumatoid arthritis: drugs versus underlying disease
Source: Annual Congress 2009 - Lung disease in rheumatoid arthritis treated with tumour necrosis factor inhibitors: a pulmonary perspective
Year: 2009


Infliximab treatment in patients with interstitial lung disease and rheumatoid arthritis
Source: Eur Respir J 2002; 20: Suppl. 38, 587s
Year: 2002